Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy
- 1 December 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 118 (12) , 1414.e21-1414.e27
- https://doi.org/10.1016/j.amjmed.2005.07.050
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Diabetic nephropathy: how effective is treatment in clinical practice?QJM: An International Journal of Medicine, 2002
- Diabetic NephropathyDiabetes Care, 2002
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensionsAmerican Journal of Kidney Diseases, 1999
- The care of patients with diabetic nephropathy: audit, feedback, and improvementQJM: An International Journal of Medicine, 1999
- Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure?QJM: An International Journal of Medicine, 1999
- Abysmal prognosis of patients with type 2 diabetes entering dialysisNephrology Dialysis Transplantation, 1999
- Effect of antihypertensive treatment on kidney function in diabetic nephropathy.BMJ, 1987